Form 4: CFO Ben Taylor's Tax-Related Stock Disposition

Recursion Pharmaceuticals' CFO, Ben R. Taylor, disposed of 11,908 shares of Class A Common Stock to cover tax obligations related to restricted stock unit settlement.

Summary

• Ben R. Taylor, Chief Financial Officer of Recursion Pharmaceuticals, Inc. (RXRX), disposed of 11,908 shares of Class A Common Stock.
• The transaction occurred on November 17, 2025, at a price of $4.14 per share.
• This disposition was made to satisfy tax withholding and remittance obligations associated with the net settlement of restricted stock units.
• Following this transaction, Mr. Taylor beneficially owns 792,261 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding purposes related to restricted stock unit vesting, which is a neutral event with no significant positive or negative implications for the company's operations or financial health.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

This filing reports a routine insider transaction for tax purposes, which does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine tax-related disposition, not a discretionary sale.
• Employees: Reflects standard equity compensation practices and associated tax obligations for executives.

Key Dates

Recommendation

This Form 4 details a standard tax-related disposition of shares by a company officer following the vesting of restricted stock units. Such routine transactions are not indicative of changes in company fundamentals or future prospects and therefore do not warrant a change in investment recommendation.

Keywords

Recursion Pharmaceuticals, RXRX, Ben R. Taylor, CFO, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Restricted Stock Units, Equity Compensation